|Age:||18 years or older|
|Keywords:||EGFR-mutant non-small cell lung cancer, cancer, lung cancer, non-small cell lung cancer, chemotherapy, Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer, Stage I-IIIA Cancer|
|Type:||Other study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.